For instance, treatment of subarachnoid hemorrhage with bone marrow mesenchymal stem cells resulted in upregulation of CHAC1/BOTCH, which significantly reduced neuroinflammation by blocking NOTCH1 signaling (Li et al., 2019; Liu, W. et al., 2019). This evidence concerns the gene CHAC1 and subarachnoid hemorrhage.